Clinical Trial Update: A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan

View source ↗

Summary

Sanofi is conducting a study to evaluate the impact of efanesoctocog alfa on long-term joint health in participants with Hemophilia A in Taiwan. The trial is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Altuviiio (efanesoctocog alfa)

Snippet

Sponsor: Sanofi | Conditions: Hemophilia A | Status: RECRUITING